DNLI
Price
$14.10
Change
-$0.39 (-2.69%)
Updated
Jun 27 closing price
Capitalization
2.05B
32 days until earnings call
FENC
Price
$8.25
Change
-$0.03 (-0.36%)
Updated
Jun 27 closing price
Capitalization
227.38M
39 days until earnings call
Interact to see
Advertisement

DNLI vs FENC

Header iconDNLI vs FENC Comparison
Open Charts DNLI vs FENCBanner chart's image
Denali Therapeutics
Price$14.10
Change-$0.39 (-2.69%)
Volume$4.08M
Capitalization2.05B
Fennec Pharmaceuticals
Price$8.25
Change-$0.03 (-0.36%)
Volume$196.82K
Capitalization227.38M
DNLI vs FENC Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. FENC commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and FENC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (DNLI: $14.10 vs. FENC: $8.25)
Brand notoriety: DNLI and FENC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 276% vs. FENC: 224%
Market capitalization -- DNLI: $2.05B vs. FENC: $227.38M
DNLI [@Biotechnology] is valued at $2.05B. FENC’s [@Biotechnology] market capitalization is $227.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileFENC’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • FENC’s FA Score: 0 green, 5 red.
According to our system of comparison, FENC is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 2 TA indicator(s) are bullish while FENC’s TA Score has 1 bullish TA indicator(s).

  • DNLI’s TA Score: 2 bullish, 7 bearish.
  • FENC’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, FENC is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +1.51% price change this week, while FENC (@Biotechnology) price change was +6.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

FENC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.05B) has a higher market cap than FENC($227M). FENC YTD gains are higher at: 30.538 vs. DNLI (-30.815). FENC has higher annual earnings (EBITDA): -10.34M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. FENC (22.7M). FENC has less debt than DNLI: FENC (19.4M) vs DNLI (48.6M). FENC has higher revenues than DNLI: FENC (30.9M) vs DNLI (0).
DNLIFENCDNLI / FENC
Capitalization2.05B227M902%
EBITDA-505.16M-10.34M4,884%
Gain YTD-30.81530.538-101%
P/E RatioN/A60.43-
Revenue030.9M-
Total Cash818M22.7M3,604%
Total Debt48.6M19.4M251%
FUNDAMENTALS RATINGS
DNLI vs FENC: Fundamental Ratings
DNLI
FENC
OUTLOOK RATING
1..100
6355
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
6342
P/E GROWTH RATING
1..100
9998
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FENC's Valuation (90) in the Biotechnology industry is in the same range as DNLI (93). This means that FENC’s stock grew similarly to DNLI’s over the last 12 months.

FENC's Profit vs Risk Rating (86) in the Biotechnology industry is in the same range as DNLI (100). This means that FENC’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's SMR Rating (94) in the Biotechnology industry is in the same range as FENC (100). This means that DNLI’s stock grew similarly to FENC’s over the last 12 months.

FENC's Price Growth Rating (42) in the Biotechnology industry is in the same range as DNLI (63). This means that FENC’s stock grew similarly to DNLI’s over the last 12 months.

FENC's P/E Growth Rating (98) in the Biotechnology industry is in the same range as DNLI (99). This means that FENC’s stock grew similarly to DNLI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLIFENC
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGZFF0.110.01
+6.92%
Pan Global Resource, Inc.
WHTCF2.880.04
+1.33%
Well Health Technologies Corp.
ATMH0.08N/A
N/A
ALL THINGS MOBILE ANALYTIC INC.
CHBAF8.01N/A
N/A
Chiba Bank, Ltd. (The)
OEZVY16.15N/A
N/A
Verbund AG

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-2.69%
BEAM - DNLI
61%
Loosely correlated
-1.98%
NRIX - DNLI
59%
Loosely correlated
+0.17%
RGNX - DNLI
58%
Loosely correlated
-4.11%
ARWR - DNLI
57%
Loosely correlated
+0.06%
ATXS - DNLI
57%
Loosely correlated
N/A
More

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
-0.36%
DNLI - FENC
48%
Loosely correlated
-2.69%
CLDX - FENC
45%
Loosely correlated
-4.16%
IDYA - FENC
44%
Loosely correlated
-4.13%
BEAM - FENC
44%
Loosely correlated
-1.98%
ATXS - FENC
43%
Loosely correlated
N/A
More